Search Details

Word: phrma (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...When asked if PhRMA member companies will continue to invest in direct advertising, spokesman Jennifer Page said that PhRMA has no knowledge of the companies’ business decisions due to federal anti-trust laws that prohibit collusion on business practices...

Author: By June Q. Wu, CRIMSON STAFF WRITER | Title: HMS Study Finds No Influence from Direct Drug Ads | 9/11/2008 | See Source »

Moore's current opponents have tried to launch pre-emptive strikes at the director and his moviemaking practices. On June 13, the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents leading drugmakers such as Eli Lilly, Merck and GlaxoSmithKline, issued a statement dismissing Moore as "a political activist with a track record for sensationalism." PhRMA went on to say "a review of America's health care system should be balanced, thoughtful and well-researched" before adding, "Unfortunately, you won't get that from Michael Moore." America's Health Insurance Plans, whose members include HMOs Aetna and Cigna, handed...

Author: /time Magazine | Title: Health Care's War Against Sicko | 6/25/2007 | See Source »

...Harvard Medical School. “People immediately assume that the effect is bad,” Campbell said. “It can be potentially helpful,” adding that such relationships help educate physicians about new drugs and treatments. The Pharmaceutical Research and Manufacturers of America (PhRMA), a Washington-based trade group funded by pharmaceutical companies, maintains that its current practices are necessary. Ken Johnson, a senior vice president of PhRMA wrote in an e-mailed statement that “pharmaceutical marketing is one of several important ways for health care providers to receive the information...

Author: By Joshua R. Stein, CRIMSON STAFF WRITER | Title: Study Reveals Gifts to Physicians | 4/27/2007 | See Source »

...drug industry, fired back that the GAO report only confirms that developing new drugs has become a more expensive, difficult and risky exercise for manufacturers. "Researchers are tackling increasingly complex diseases using new tools-such as genomics, proteomics and nanotechnology-that will take years to bear fruit," says PhRMA Senior Vice President Ken Johnson, adding that "more than 2,000 new medicines are in development, including 646 medicines for cancer, 146 for heart disease and stroke, 77 for AIDS, and 56 for diabetes...

Author: /time Magazine | Title: Too Little Bang for the Buck in Drug Research? | 12/27/2006 | See Source »

...decades, taking gifts from drugmakers has been business as usual for doctors. The pharmaceutical industry spent $22 billion on marketing to physicians (including free samples) in 2003, up from $12.1 billion in 1999, according to data from Pharmaceutical Research and Manufacturers of America (PhRMA). The industry is on track to spend almost $3 billion in 2005 solely on meetings and events for physicians, according to Verispan, a health-care market-research firm in Pennsylvania. The drug industry argues, with reason, that gift giving evolved as a necessary tool for sharing information about new drugs with busy physicians who needed incentives...

Author: /time Magazine | Title: Fighting the Freebies | 11/6/2005 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | Next